A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 393 (2-3) , 127-130
- https://doi.org/10.1016/j.neulet.2005.09.058
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Metabotropic glutamate receptors as novel targets for anxiety and stress disordersNature Reviews Drug Discovery, 2005
- Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior testEuropean Journal of Pharmacology, 2004
- Selective action of (−)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shellNeuropharmacology, 2004
- MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activityNeuropharmacology, 2004
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Depletion of mesolimbic dopamine during behavioral despair: Partial reversal by chronic imipramineEuropean Journal of Pharmacology, 1993
- Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization studyJournal of Comparative Neurology, 1993
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Chronic desipramine enhances the effect of locally applied amphetamine on interstitial concentrations of dopamine in the nucleus accumbensEuropean Journal of Pharmacology, 1991
- Neuroleptics and operant behavior: The anhedonia hypothesisBehavioral and Brain Sciences, 1982